New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2014
16:17 EDTESPRAisling Capital II reports 13.8% passive stake in Esperion Therapeutics
News For ESPR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 27, 2015
09:26 EDTESPROn The Fly: Pre-market Movers
Subscribe for More Information
06:07 EDTESPREsperion assumed with a Buy at Citigroup
Citigroup says it sees an unmet need for Esperion's oral LDL cholesterol lowering agent ETC-1002. It assumed coverage of the stock with a Buy rating and raised its price target for shares to $130 from $67.
March 25, 2015
16:50 EDTESPRDomain Partners lowers stake in Esperion to 11.2% from 13.3%
Subscribe for More Information
March 20, 2015
07:42 EDTESPRBioCentury to hold a conference
Subscribe for More Information
March 19, 2015
08:48 EDTESPREsperion 1.75M share Secondary priced at $100.00
Subscribe for More Information
March 17, 2015
19:42 EDTESPROn The Fly: After Hours Movers
Subscribe for More Information
17:29 EDTESPREsperion files to sell $150M of common stock
Credit Suisse Securities (USA) LLC is acting as lead book-running manager for the proposed offering, with RBC Capital Markets, LLC and UBS Securities LLC acting as joint book-running managers.
16:26 EDTESPROn The Fly: Closing Wrap
Subscribe for More Information
12:38 EDTESPROn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday, with the Dow falling about 1%. The market opened in negative territory and proceeded to gain additional downside momentum in early trading. Data on housing starts was not good, even accounting for bad weather in many areas of the country, and the prospect of interest rate increases on the horizon may have some fearing that the housing market recovery is in danger of stalling. Adding to the weakness in stocks may have been the further slide in crude oil prices, which pushed benchmark U.S. crude oil below $43 per barrel earlier in the session. ECONOMIC EVENTS: In the U.S., housing starts plunged 17% to an 897K rate in February, widely undershooting expectations for starts to be down 2.4% to a 1.04M rate, but much of the slide was attributed to weather. Building permits rose 3% to a rate of 1.092M, which was better than the expected 0.5% growth to a 1.065M rate. In Europe, Germany's ZEW Center investor confidence index climbed to 54.8 from 53 last month, though that fell short of the 59.4 consensus forecast. In Asia, the Shanghai Composite index rose 1.6% to close at its highest level in over 6 years. COMPANY NEWS: Apple (AAPL) is preparing to launch an online TV service later this year, according to reports from The Wall Street Journal and the Financial Times. After the reports, Piper Jaffray analyst Gene Munster said he believes Apple's online TV service launch would lay the groundwork for an actual television launch sometime in 2016. Munster estimates that at an average selling price of $1,750, a television could add about 7% to Apple's 2017 revenue. MAJOR MOVERS: Among the notable gainers was Black Diamond (BDE), which jumped 30% after the company reported was then expected quarterly results and guidance but also announced it has hired two banks to help it explore its strategic alternatives. Also higher was Esperion (ESPR), which rose 15% after the company's phase 2b study of ETC-1002, a product in development for patients with hypercholesterolemia on stable statin therapy, met its primary endpoints. Among the noteworthy losers was Himax (HIMX), which dropped 9% after BofA Merrill Lynch downgraded the stock two notches to Underperform from Buy. Also lower following its earnings report was magicJack (CALL), which fell 19%. INDEXES: Near midday, the Dow was down 152.00, or 0.85%, to 17,825.42, the Nasdaq was down 8.39, or 0.17%, to 4,921.12, and the S&P 500 was down 11.39, or 0.55%, to 2,069.80.
12:14 EDTESPREsperion price target raised to $130 from $100 at Credit Suisse
Credit Suisse raised its price target on Esperion to $130 from $100 citing the company's phase 2b study of ETC-1002, which met its primary endpoints. The firm has an Outperform rating on the shares.
10:02 EDTESPRHigh option volume stocks
High option volume stocks: NGL ARCO ENR OIL SNI ESPR CYH WIN CRZO DISH
09:25 EDTESPROn The Fly: Pre-market Movers
Subscribe for More Information
07:35 EDTESPREsperion announces phase 2b study of ETC-1002 met primary endpoints
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use